Antioxidants that protect mitochondria reduce interleukin-6 and oxidative stress, improve mitochondrial function, and reduce biochemical markers of organ dysfunction in a rat model of acute sepsis

British Journal of Anaesthesia

Volumn 110, Issue 3, 2013, Pages 472-480

  Lowes, D A ^a   Webster, N R ^a   Murphy, M P ^b   Galley, H F ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

co enzyme Q10; interleukin 10; interleukin 6; melatonin; sepsis; tocopherol

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIOXIDANT; CREATININE; INTERLEUKIN 6; MELATONIN; MITOE ANTIOXIDANT; MITOQ ANTIOXIDANT; SODIUM CHLORIDE; UBIDECARENONE; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL FUNCTION; CELL PROTECTION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE MARKER; ENZYME ACTIVITY; INFLAMMATION; MALE; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SEPSIS;

EID: 84874355329     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aes577     Document Type: Article

References (46)

1. Marshall JC, Vincent JL, Guyatt G, et al. Outcome measures for clinical research in sepsis: A report of the 2nd Cambridge Colloquium of the International Sepsis Forum. Crit Care Med 2005; 33: 1708-1706
2. Turrens JF. Mitochondrial formation of reactive oxygen species. J Physiol 2003; 552: 335-44
3. James AM, Murphy MP. How mitochondrial damage affects cell function. J Biomed Sci 2002; 9: 475-87
4. Exline MC, Crouser ED. Mitochondrial mechanisms of sepsis induced organ failure. Frontiers Biosc 2008; 13: 5031-5041
5. Ruggieri AJ, Levy RJ, Deutschman CS. Mitochondrial dysfunction and resuscitation in sepsis. Crit Care Clin 2010; 26: 567-75
6. Víctor VM, Espulgues JV, Hernández-Mijares A, Rocha M. Oxidative stress and mitochondrial dysfunction in sepsis: A potential therapy with mitochondria-targeted antioxidants. Infect Disord Drug Targets 2009; 9: 376-89
7. Galley HF. Oxidative stress and mitochondrial dysfunction in sepsis. Br J Anaesth 2011; 107: 57-64
8. Smith RA, Porteous CM, Coulter CV, Murphy MP. Selective targeting of an antioxidant to mitochondria. Eur J Biochem 1999; 263: 709-16
9. Galano A. On the direct scavenging activity of melatonin towards hydroxyl and a series of peroxyl radicals. Phys Chem Chem Phys 2011; 13: 7178-7188
10. Stetinová V, Smetanová L, Grossmann V,Anzenbacher P. In vitro and in vivo assessment of the antioxidant activity of melatonin and related indole derivatives. Gen Physiol Biophys 2002; 21: 153-62
11. Lowes DA, Almawash AM, Webster NR, Reid V, Galley HF. Role of melatonin and indole-derivatives on endothelial cells in an in vitro model of sepsis. Br J Anaesth 2011; 107: 193-201
12. Lowes DA, Thottakam BMVJ, Webster NR, Murphy MP, Galley HF. The mitochondria-targeted antioxidant MitoQ protects against organ damage in a lipopolysaccharideYpeptidoglycan model of sepsis. Free Radic Biol Med 2008; 45: 1559-1565
13. Minter BE, Lowes DA, Webster NR, Galley HF. Mitochondria targeted vitamin E in an endothelial model of sepsis (Abstract). Br J Anaesth 2010; 104: 525-6P
14. Wray GM, Foster SJ, Hinds CJ, Thiemermann C. A cell wall component from pathogenic and non-pathogenic gram-positive bacteria (peptidoglycan) synergises with endotoxin to cause the release of TNFa, nitric oxide production, shock, and multiple organ dysfunction in the rat. Shock 2001; 15: 135-42
15. Ozer J, Ratner M, Shaw M, Bailey W, Schomaker S. The current state of serum biomarkers of hepatotoxicity. Toxicology 2008; 245: 194-205
16. Peake M, Whiting M. Measurement of serum creatinine - current status and future goals. Clin Biochem Rev 2006; 27: 173-84
17. Frezza C, Cipolat S, Scorrano L. Organelle isolation: Functional mitochondria from mouse liver, muscle and cultured fibroblasts. Nat Protocols 2007; 2: 287-95
18. Hughes G, Murphy MP, Ledgerwood EC. Mitochondrial reactive oxygen species regulate the temporal activation of nuclear factor kappaB to modulate tumour necrosis factor-induced apoptosis: Evidence from mitochondria-targeted antioxidants. Biochem J 2005; 389: 83-89
19. Naik E, Dixit VM. Mitochondrial reactive oxygen species drive pro-inflammatory cytokine production. J Exp Med 2011; 208: 417-20
20. Garrabou G, Morén C, López S, et al. The effects of sepsis on mitochondria. J Infect Dis 2012; 205: 392-400
21. Shang Y, Xu SP, Wu Y, et al. Melatonin reduces acute lung injury in endotoxemic rats. Chin Med J (Engl) 2009; 122: 1388-1393
22. James AM, Sharpley MS, Manas AR, et al. Interaction of the mitochondria-targeted antioxidant MitoQ with phospholipid bilayers and ubiquinone oxidoreductases. J Biol Chem 2007; 282: 14708-18
23. Radi R, Cassina A, Hodara R. Nitric oxide and peroxynitrite interactions with mitochondria. Biol Chem 2002; 383: 401-409
24. Apostolova N, Garcia-Bou R, Hernandez-Mijares A, Herance R, Rocha M, Victor VM. Mitochondrial antioxidants alleviate oxidative and nitrosative stress in a cellular model of sepsis. Pharm Res 2011; 28: 2910-2919
25. Choumar A, Tarhuni A, Lettéron P, et al. Lipopolysaccharide- induced mitochondrial DNA depletion. Antioxid Redox Signal 2011; 15: 2837-2854
26. Mitchell T, Rotaru D, Saba H, Smith RAJ, Murphy MP, MacMillan-Crow LA. The mitochondria-targeted antioxidant mitoquinone protects against cold storage injury of renal tubular cells and rat kidneys. J Pharmacol Exp Ther 2011; 336: 682-92
27. Luchetti F, Canonico B, Betti M, et al. Melatonin signaling and cell protection function. FASEB J 2010; 24: 3603-3624
28. Gilad E, Cuzzocrea S, Zingarelli B, Salzman AL, Szabó C. Melatonin is a scavenger of peroxynitrite. Life Sci 1997; 60: PL169-74
29. Limón-Pacheco JH, Gonsebatt ME. The glutathione system and its regulation by neurohormone melatonin in the central nervous system. Cent Nerv Syst Agents Med Chem 2010; 10: 287-97
30. Mauriz JL, Collado PS, Veneroso C, Reiter RJ, González-Gallego J. A review of the molecular aspects of melatonin's antiinflammatory actions: Recent insights and new perspectives. J Pineal Res 2013; 54: 1-14
31. Smith RAJ, Porteous CM, Gane AM, Murphy MP. Delivery of bioactive molecules to mitochondria in vivo. Proc Natl Acad Sci USA 2003; 100: 5407-5412
32. Zang QS, Sadek H, Maass DL, et al. Specific inhibition of mitochondrial oxidative stress suppresses inflammation and improves cardiac function in a rat pneumonia-related sepsis model. Am J Physiol Heart Circ Physiol 2012; 302: H1847-59
33. Venegas C, García JA, Escames G, et al. Extrapineal melatonin: Analysis of its subcellular distribution and daily fluctuations. J Pineal Res 2012; 52: 217-27
34. Vanhorebeek I, De Vos R, Mesotten D, Wouters PJ, De Wolf-Peeters C, Van den Berghe G. Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients. Lancet 2005; 365: 53-59
35. Davies NA, Cooper CE, Stidwill R, Singer M. Inhibition of mitochondrial respiration during early stage sepsis. Adv Exp Med Biol 2003; 530: 725-36
36. Novotny AR, Reim D, Assfalg V, et al. Mixed antagonist response and sepsis severity-dependent dysbalance of pro- And antiinflammatory responses at the onset of postoperative sepsis. Immunobiology 2012; 217: 616-21
37. Maj M, Sriskandarajah N, Hung V, et al. Identification of drug candidates which increase cytochrome c oxidase activity in deficient patient fibroblasts. Mitochondrion 2011; 11: 264-72
38. Carrillo-Vico A, Lardone PJ, Naji L, et al. Beneficial pleiotropic actions of melatonin in an experimental model of septic shock in mice: Regulation of pro-/anti-inflammatory cytokine network, protection against oxidative damage and anti-apoptotic effects. J Pineal Res 2005; 39: 400-408
39. Li Volti G, Musumeci T, Pignatello R, et al. Antioxidant potential of different melatonin-loaded nanomedicines in an experimental model of sepsis. Exp Biol Med 2012; 237: 670-677
40. Nickkholgh A, Schneider H, Sobirey M, et al. The use of high-dose melatonin in liver resection is safe: First clinical experience. J Pineal Res 2011; 50: 381-388
41. Bedirli N, Demirtas CY, Akkaya T, et al. Volatile anesthetic preconditioning attenuated sepsis induced lung inflammation. J Surg Res 2012; 178: E17-23
42. Tung A, Herrera S, Fornal CA, Jacobs BL. The effect of prolonged anesthesia with isoflurane, propofol, dexmedetomidine, or ketamine on neural cell proliferation in the adult rat. Anesth Analg 2008; 106: 1772-1777
43. Smith RA, Murphy MP. Mitochondria-targeted antioxidants as therapies. Discov Med 2011; 11: 106-14
44. Bourne RS, Mills GH, Minelli C. Melatonin therapy to improve nocturnal sleep in critically ill patients: Encouraging results from a small randomised controlled trial. Crit Care 2008; 12: R52
45. Chahbouni M, Escames G, Venega C, et al. Melatonin treatment normalizes plasma pro-inflammatory cytokines and nitrosative/oxidative stress in patients suffering from Duchenne muscular dystrophy. J Pineal Res 2010; 48: 282-289
46. Gitto E, Karbownik M, Reiter RJ, et al. Effects of melatonin treatment in septic newborns. Pediatr Res 2001; 50: 756-60